LINC-ROR and breast carcinoma: NOB activates ROR response elements of ROR binding to IκBα promoter via NOB-ROR axis in vivo and in vitro, inhibits p65 nuclear translocation via NF-κB pathway, and significantly inhibits the proliferation of breast cancer cells [27].